Polyunsaturated fatty acids in cystic fibrosis are related to nutrition and clinical expression of the disease [1]

Journal of Pediatric Gastroenterology and Nutrition

Volumn 45, Issue 4, 2007, Pages 488-489

  Walkowiak, Jaroslaw ^a   Lisowska, Aleksandra ^a   Blaszczynski, Michal ^a   Przyslawski, Juliusz ^a   Walczak, Mieczyslaw ^b  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b POMERANIAN MEDICAL UNIVERSITY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; DIHOMO GAMMA LINOLENIC ACID; DOCOSAHEXAENOIC ACID; LINOLEIC ACID; LINOLENIC ACID; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PHOSPHOLIPID; POLYUNSATURATED FATTY ACID;

BODY WEIGHT; CALORIC INTAKE; CORRELATION ANALYSIS; CYSTIC FIBROSIS; DIETARY INTAKE; FAT INTAKE; FORCED EXPIRATORY VOLUME; HUMAN; LETTER; LUNG FUNCTION; MEMBRANE FLUIDITY; MULTIPLE REGRESSION; NUTRITION; NUTRITIONAL STATUS; PHOSPHOLIPID BLOOD LEVEL; PRIORITY JOURNAL; STEATORRHEA;

ADOLESCENT; ADULT; ARACHIDONIC ACID; BILE ACIDS AND SALTS; CHILD; CHILD, PRESCHOOL; CYSTIC FIBROSIS; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; ENERGY INTAKE; FATTY ACIDS, UNSATURATED; FORCED EXPIRATORY VOLUME; HUMANS; LINOLEIC ACID; LUNG; NUTRITIONAL STATUS; PHOSPHOLIPIDS; REFERENCE VALUES; RESPIRATORY FUNCTION TESTS;

EID: 37349060296     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/MPG.0b013e3180690da9     Document Type: Letter

References (11)

1. Colombo C, Bennato V, Constantini D, et al. Dietary and circulating polyunsaturated fatty acids in cystic fibrosis: are they related to clinical outcomes? J Pediatr Gastroenterol Nutr 2006;43:660-5.
2. Walkowiak J, Wilczynski M, Boleslawska I, et al. The predominance of omega-6 polyunsaturated fatty acids in cystic fibrosis despite low arachidonic acid levels. Acta Paediatr 2003;92:1354-5.
3. Strandvik B, Brönnegard M, Gilljam H, et al. Relation between defective regulation of arachidonic acid release and symptoms in cystic fibrosis. Scand J Gastroenterol Suppl 1988;143:1-4.
4. Stillwell W, Jenski LJ, Crump FT, et al. Effect of docosahexaenoic acid on mouse mitochondrial membrane properties. Lipids 1997;32:497-506.
5. Keicher U, Koletzko B, Reinhardt B. Omega-3 fatty acids suppress the enhanced production of 5-lipo-oxygenase products from polymorph neutrophil granulocytes in cystic fibrosis. Eur J Clin Invest 1995;25:915-9.
6. Walkowiak J, Wilczynski M, Bolesławska I, et al. Deficiency of linoleic acid in cystic fibrosis patients: nutrition and clinical status [in Polish]. Metab Żyw Człow 2003;30:736-40.
7. Walkowiak J, Wilczynski M, Boleslawska I, et al. Normal polynsturated fatty amid profile in cystic fibrosis patients with mild clinical expression of the disease [in Polish]. Metab Żyw Człow 2003;30:8703.
8. Shoff SM, Ahn H-Y, Davis L, et al. Temporal associations among energy intake, plasma linoleic acid, and growth improvement in response to treatment initiation after diagnosis of Cystic fibrosis. Pediatrics 2006;117:391-400.
9. Mischler EH, Parrell SW, Farrell PM, et al. Correction of linoleic acid deficiency in cystic fibrosis. Pediatr Res 1986;20:36-41.
10. van Egmond AW, Kosorok MR, Koscik R, et al. Effect of linoleic acid intake on growth of infants with cystic fibrosis. Am J Clin Nutr 1996;63:746-52.
11. Steinkamp G, Demmelmair H, Ruhl-Bagheri I, et al. Energy supplements rich in linoleic acid improve body weight and essential fatty acid status of cystic fibrosis patients. J Pediatr Gastroenterol Nutr 2000;31:418-23.